| Title: |
The Cambridge Centre for Myelin Repair trial Two (CCMR Two): a trial protocol for a phase 2a, randomised, double-blind, placebo-controlled clinical trial of the ability of the combination of metformin and clemastine to promote remyelination in people with relapsing-remitting multiple sclerosis already on disease-modifying therapy |
| Authors: |
Riboni-Verri, GioiaAff1; McMurran, Christopher E.Aff1; Mukherjee, TrishaAff1; Daruwalla, CyrusAff1; Holland, JonathonAff1; Gautam, RiddhimaAff1; Chen, Benson S.Aff1; Cutting, EmmaAff1; Qian, WendiAff2; MacManus, DavidAff3, Aff4; Chard, Declan T.Aff3, Aff4; Brown, J. William L.Aff1, Aff3, Aff4; Coles, Alasdair J.Aff1; Cunniffe, Nick G.Aff1, IDs13063025092542_cor1 |
| Source: |
Trials. 26(1) |
| Database: |
Springer Nature Journals |